Ashley is a Professor of Respiratory Medicine at the North West Lung Centre and the University of Manchester. Also a Consultant Respiratory Physician at the University Hospital of South Manchester, where he is the Clinical Director for the Directorate of Respiratory Medicine and Allergy. He has been Chairman of the Clinical Assembly of the European Respiratory Society, and past-President of the British Thoracic Society. He was awarded the OBE in 2006 for his Chairmanship of the Medical Technical Committee to the Montreal Protocol for the previous decade. He contributed to the Nobel Peace Prize in 2007 with IPCC/Al Gore. He was awarded Fellowship of the Academy of Medical Sciences in 2008.
Professor Clare Mills
Co-founder and Chief Scientific Officer
Clare is a Professor of Molecular Allergology at the University of Manchester, is based in the Manchester Institute of Biotechnology, and is part of the Respiratory and Allergy Research Centre, which is based at the University Hospital of South Manchester. Building on the successful four-year, EU-funded, multidisciplinary, multinational EuroPrevall food allergy project that began in 2005 and which she co-ordinated, she is now the head of IFAAM, the follow on EU-funded research project on food allergy that began in 2013.
Norman is a qualified Chartered Management Accountant and has 15 years’ experience in arranging early stage business angel and venture capital funding. Following training in accountancy with GKN, he joined PriceWaterhouseCoopers, working on many consultancy assignments with both SME and multi-national companies. Following this, he returned to industry with director roles in the paper manufacturing and food manufacturing sectors in the UK. Norman founded Acceleris Limited in 2000, an FCA regulated fund management and corporate finance firm specialising in EIS led investment transactions. He is a director of Seneca Partners, the parent company of Acceleris and holds other board positions in companies for which Acceleris has arranged finance.